The obesity paradox in heart failure: Accepting reality and making rational decisions

Clinical Pharmacology and Therapeutics

Volumn 90, Issue 1, 2011, Pages 188-190

  Anker, S D ^a,b   Von Haehling, S ^a,c  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b IRCCS SAN RAFFAELE PISANA   (Italy)

^c DZHK GERMAN CENTRE FOR CARDIOVASCULAR RESEARCH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BARIATRIC SURGERY; BODY MASS; EXERCISE; HEART FAILURE; HUMAN; MEDICAL DECISION MAKING; MEDICAL INFORMATION; MEDICAL PRACTICE; MORTALITY; OBESITY; PRIORITY JOURNAL; PROGNOSIS; QUALITY OF LIFE; RISK FACTOR; STATISTICAL ANALYSIS; SURVIVAL RATE; WEIGHT REDUCTION;

EID: 79959380391     PISSN: 00099236     EISSN: 15326535     Source Type: Journal    
DOI: 10.1038/clpt.2011.72     Document Type: Article

References (10)

1. Fonarow, G.C., Srikanthan, P., Costanzo, M.R., Cintron, G.B. & Lopatin, M.; ADHERE Scientific Advisory Committee and Investigators. An obesity paradox in acute heart failure: analysis of body mass index and inhospital mortality for 108,927 patients in the Acute Decompensated Heart Failure National Registry. Am. Heart J. 153, 74-81 (2007). (Pubitemid 44880872)
2. von Haehling, S. et al. Diabetes mellitus, cachexia and obesity in heart failure: rationale and design of the Studies Investigating Co-morbidities Aggravating Heart Failure (SICA-HF). J. Cachex. Sarcopenia Muscle 1, 187-194 (2010).
3. Oreopoulos, A., Padwal, R., Kalantar-Zadeh, K., Fonarow, G.C., Norris, C.M. & McAlister, F.A. Body mass index and mortality in heart failure: a meta-analysis. Am. Heart J. 156, 13-22 (2008). (Pubitemid 351862293)
4. von Haehling, S. & Anker, S.D. Cachexia as a major underestimated and unmet medical need: facts and numbers. J. Cachex. Sarcopenia Muscle 1, 1-5 (2010).
5. Decision making paradox. . Accessed 7 February 2011.
6. Adamopoulos, C. et al. Absence of obesity paradox in patients with chronic heart failure and diabetes mellitus: a propensity-matched study. Eur. J. Heart Fail. 13, 200-206 (2011).
7. Kenchaiah, S. et al. Obesity and the risk of heart failure. N. Engl. J. Med. 347, 305-313 (2002). (Pubitemid 34815352)
8. Whitlock, G. et al.; Prospective Studies Collaboration. Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies. Lancet 373, 1083-1096 (2009).
9. Pocock, S.J. et al. Weight loss and mortality risk in patients with chronic heart failure in the candesartan in heart failure: assessment of reduction in mortality and morbidity (CHARM) programme. Eur. Heart J. 29, 2641-2650 (2008).
10. Rozentryt, P. et al. The effects of a high-caloric protein-rich oral nutritional supplement in patients with chronic heart failure and cachexia on quality of life, body composition, and inflammation markers: a randomized, doubleblind pilot study. J. Cachex. Sarcopenia Muscle 1, 35-42 (2010).